China expands testing to 18 nations in vaccine charm offensive

Beijing targets Belt and Road countries but safety concerns persist

20200917N sinovac

A COVID-19 vaccine candidate from Sinovac Biotech. Three Chinese companies are now conducting Phase 3 trials abroad. © Reuters

SHIN WATANABE and TSUKASA HADANO, Nikkei staff writers

DALIAN/BEIJING -- China is on track to conduct final clinical trials for a coronavirus vaccine in 18 countries by the end of the year, bolstering its vaccine diplomacy in emerging economies that are struggling to contain the virus.

Sponsored Content

About Sponsored ContentThis content was commissioned by Nikkei's Global Business Bureau.